CSIMarket
 
Celgene Corp  (CELG)
Other Ticker:  
 
 

Celgene's Customers Performance

CELG

 
CELG's Source of Revenues In the Q3, Celgene Corp's corporate clients experienced a reduction by -2.59 % in their costs of revenue, compared to a year ago, sequentially costs of revenue were trimmed by -24.86 %. During the corresponding time, Celgene Corp recorded revenue increase by 16.14 % year on year, sequentially revenue grew by 2.73 %. While revenue at the Celgene Corp's corporate clients recorded rose by 23.84 % year on year, sequentially revenue fell by -1.42 %.

List of CELG Customers




Customers of Celgene Corp saw their costs of revenue decrease by -2.59 % in Q3 compare to a year ago, sequentially costs of revenue were trimmed by -24.86 %, for the same period Celgene Corp recorded revenue increase by 16.14 % year on year, sequentially revenue grew by 2.73 %.

List of CELG Customers


   
Customers Net Income grew in Q3 by Customers Net margin grew to
29.46 % 3.96 %



Celgene's Customers, Q3 2019 Revenue Growth By Industry
Customers in Construction Raw Materials Industry -19.16 %   
Customers in Accident & Health Insurance Industry      28.12 %
Customers in Life Insurance Industry      13.09 %
Customers in Property & Casualty Insurance Industry      5.41 %
Customers in Investment Services Industry -28.77 %   
Customers in Miscellaneous Financial Services Industry      12.13 %
Customers in Healthcare Facilities Industry      1.85 %
Customers in Pharmacy Services & Retail Drugstore Industry      33.19 %
Customers in Grocery Stores Industry      1.07 %
     
• Customers Valuation • Customers Mgmt. Effect.


Celgene's Comment on Sales, Marketing and Customers



We promote our brands globally through our commercial organization which supports our currently marketed brands and prepares for the launches of new products, as well as new indications for existing products. We have a team of dedicated market access professionals to help physicians, patients and payers understand the value our products deliver. Given our goal to ensure that patients who might benefit from our therapies have the opportunity to do so and given the complex reimbursement environment in the United States, we offer the services of Celgene Patient Support® or similar outside services to serve as a dedicated, central point of contact for patients and healthcare professionals who use or prescribe Celgene products. Celgene Patient Support® is a free service that helps patients and healthcare professionals navigate the challenges of reimbursement, providing information about co-pay assistance and answering questions about obtaining Celgene products.

In most countries, we promote our products through our own sales organizations. In some countries, particularly in Latin America, we partner with third-party distributors. Generally, we distribute our products through commonly used channels in local markets. However, REVLIMID®, POMALYST®/IMNOVID® and THALOMID®/Thalidomide CelgeneTM are distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for their safe and appropriate distribution and use.